Supplier Type
- contract manufacturer
- Manufacturer
- custom synthesis
- Reagent
- Trader
Supplier Region
- Hyderabad(6)
- Ahmedabad(1)
- Gujarat(23)
- Mumbai(3)
- Karnataka(3)
- AndhraPradesh(2)
- Maharashtra(28)
- Telangana(33)
- Kerela(1)
- Punjab(1)
- New Delhi(1)
- Bangalore(3)
- Tamil Nadu(1)
- Haryana(2)
- Uttar Pradesh(2)
Purity
- IP / BP / USP
- above 90 %
- 99%
- 98+
- 98%
- >98%
- 97%
- 96%
- 95%
- 90%
- 90 % Above
- 0.98
Package
- 500mg
- 1g
- 5g
- 10g
- 25g
- 50g
- 100g
- 500g
- 1 kg
- 5 kg
- 10 kg
- 25kgs
- 50kgs
- 510255 Kg / 10 Kg / 25 kg
- 100500100mg or 500 mg
- 50010500 mg and 1.0 gm
- 25mg
- 50mg
- 100mg
- 250mg
- 1001100mg and 1 g
- 1kg
- 5kg
- 25kg
- 1MT
- 25125kg and 1 MT
- 10kg
-
Sumatriptan EP Impurity H
1391052-59-7
-
2-[4-[(2RS)-2-HYDROXY-3[(1-METHYLETHYL)AMINO]PROPOXY]PHENYL]ACETONITRILE
29277-73-4
-
3,5-DIIODO-4'-(4-HYDROXYPHENOXY)BENZOIC ACID
2055-97-2
-
(R)-α-[(2,2-DiMethyl-1-oxopropyl)aMino]-4-hydroxybenzeneacetic Acid
205826-86-4
-
4-Ethylaniline
589-16-2
-
Diacetic Aceclofenac
1216495-92-9
-
Montelukast
158966-92-8
-
Tadalafil KetolactaM
1346605-38-6
-
IverMectin B1 Mono-sugar Derivative
71837-27-9
-
Spiramycin EP Impurity H (Neospiramycin III)
4617-99-6
trans-11-Chloro-2-methyl-2,3,3a,12b-tetrahydro-8-oxa-2-aza-dibenzo[e,h]azulen-1-one 129385-59-7
Montelukast sodium 151767-02-1
Montelukast Sodium (IP) 151767-02-1
Montelukast sodium 151767-02-1
Valsartan n-Propyl Impurity 952652-79-8
7'-Methyl-5'-oxo-2',3'-dihydro-5'H-spiro[1,3-dioxolane-2,1'-indolizine]-6'-carbonitrile 58610-64-3
Montelukast acyl-b-D-glucuronide 188717-17-1
Amberlite IR 120 (H)